Today announced that it raised $20 million in a string D private equity funding.

The circular was led by a fresh investor, Thomas, McNerney & Companions, with participation by current investors Domain Associates, Ventures West Capital, Quaker BioVentures, TL Ventures, GrowthWorks Capital, and BDC Venture Capital.’ In addition to Celator’s clinical stage product pipeline that includes CPX-351 and CPX-1 Liposome Injection, the company has research collaborations with Cephalon and the National Tumor Institute’s Nanotechnology Characterization Laboratory. Joining Celator’s Table of Directors is normally Alex Zisson, partner, Thomas, McNerney & Partners.With more than two thirds of Us citizens classified as obese or obese1, a report in the Might/June 2010 issue of the Journal of Diet Education and Behavior examines how inspiration might be a big contributor to sticking with weight loss programs. Researchers at the University of Kentucky and University of North Carolina at Chapel Hill examined two types of motivation, controlled and autonomous, and their romantic relationship to adherence and fat loss in a 16-week Internet weight-reduction intervention. To measure the 2 types of motivation, cure Self-Regulation Questionnaire was utilized to identify those individuals motivated by intrinsic and extrinsic handles such as for example feeling that performance is the best way to greatly help oneself and producing changes for personal factors and the ones participants motivated by just exterior controls such as perceived pressure from others and feelings of guilt .